Cost-Effectiveness Analysis of Treatment of Venous Thromboembolism With Rivaroxaban Compared With Combined Low Molecular Weight Heparin/Vitamin K Antagonist

Thrombosis Journal- United Kingdom

doi 10.1186/s12959-015-0051-3

Full Text

Abstract

Available in

Categories

Hematology

Date

Authors

Publisher

Springer Science and Business Media LLC


Related search